Last update: June 30, 2015
Minimal risk for breastfeeding and infant.
Excretion into breast milk is not significant and no side effects on breastfed infants of treated mothers have been shown.
Approved for use as treatment on infants younger than a one year old.
A low oral bioavailability would protect the infant, except in the neonatal period or cases of prematurity. Calcium contained in the milk prevents it from absorption by the gut.
Be aware of the possibility of false negative results of bacterial cultures on febrile infants when the mother is on antibiotics.
We do not have alternatives for Fosfomycin since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM